FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05755048 · UNKNOWN
Trial details
- NCT number
- NCT05755048
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-28
- Primary completion
- 2025-07-30
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.